UPDATED Apr 24, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FDE | €34.40 | 7.5% | 1.2% | €179.9m | €64.07 | PE22.9x | E32.3% | n/a | Energy | ||
OSE | €5.64 | 15.7% | 34.3% | €121.6m | €7.15 | PS54.6x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
ALDVI | €1.71 | 0.7% | -58.3% | €21.0m | €6.90 | PS6.4x | E118.1% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €19.08 | -3.1% | 1.8% | €157.6m | €30.30 | PE20.7x | E38.5% | n/a | Capital Goods | ||
MLBMD | €8.00 | 0% | -14.0% | €29.2m | €14.00 | PS25.8x | E106.7% | n/a | Software | ||
AL2SI | €3.75 | 0.9% | 80.3% | €71.3m | €6.30 | PB2.6x | E108.2% | n/a | Tech | ||
ALBIZ | €5.58 | -10.9% | -6.1% | €32.5m | €10.67 | PE270.5x | E52.2% | n/a | Media | ||
ALLIX | €8.94 | 2.1% | -28.6% | €57.8m | €16.50 | PS1.6x | E101.4% | n/a | Software | ||
IPH | €2.24 | 3.5% | -16.0% | €180.7m | €6.27 | PS2.9x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
MLLCB | €3.94 | 0.5% | -12.8% | €16.9m | €4.92 | PE33.8x | E39.0% | n/a | Real Estate Management and Development | ||
ALECO | €2.96 | -1.3% | -50.5% | €10.0m | €4.50 | PB2x | E103.5% | n/a | Consumer Retailing | ||
ALESE | €5.54 | 3.0% | -25.9% | €80.6m | €11.70 | PS2x | E119.2% | n/a | Capital Goods | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | Pharmaceuticals & Biotech | ||
ALKLK | €0.83 | -15.7% | -15.7% | €6.2m | €1.10 | PB0.8x | E115.0% | n/a | Tech | ||
ALLEC | €8.05 | 1.3% | 14.2% | €68.4m | €9.00 | PS1.1x | E86.1% | 0% | Tech | ||
ADOC | €8.75 | 2.9% | 212.5% | €125.0m | €9.70 | PS11.5x | E84.1% | n/a | Pharmaceuticals & Biotech | ||
ALMUN | €0.65 | -2.1% | -77.2% | €5.8m | €1.30 | PB0.5x | E150.0% | n/a | Tech | ||
ALAGP | €0.94 | -2.7% | -83.2% | €3.3m | €2.30 | PS1.2x | E119.4% | 0% | Capital Goods | ||
ALICA | €9.86 | -1.2% | -42.0% | €79.7m | €16.00 | PE15.3x | E31.3% | 2.0% | Tech | ||
ALCUR | €5.86 | -3.9% | 119.5% | €33.4m | €7.48 | PE18.6x | E41.7% | n/a | Capital Goods | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | Pharmaceuticals & Biotech | ||
ALBPS | €0.0025 | 8.7% | -91.8% | €2.9m | n/a | PE-0.2x | E56.2% | n/a | Pharmaceuticals & Biotech | ||
ALVAL | €3.93 | 2.3% | 21.3% | €62.0m | €10.07 | PS14.1x | E63.4% | n/a | Pharmaceuticals & Biotech | ||
MEDCL | €12.10 | 6.5% | 36.6% | €347.9m | €16.75 | PS24.6x | E68.2% | n/a | Pharmaceuticals & Biotech |